Deneufbourg, J.-M. (2015). Place de la Radiothérapie dans une stratégie multidisciplinaire de traitement du cancer [Paper presentation]. Conférence Bois des roches, Vielsalm, Belgium. |
Deneufbourg, J.-M. (2008). In memoriam Jacques CLOSON. Revue Médicale de Liège, 63 (4), 169-170. |
Lutgens, L., Lammering, G., Pijls-Johannesma, M., van der Zee, J., Lambin, P., Deneufbourg, J.-M., & De Ruysscher, D. K. M. (2007). Combined use of hyperthermia and radiation therapy for treating locally advanced cervical cancer. Londres, United Kingdom: Wiley and sons LTD. doi:10.1002/14651858.CD006377 |
Jansen, N., Deneufbourg, J.-M., & Nickers, P. (15 March 2007). Adjuvant stereotactic permanent seed breast implant: A boost series in view of partial breast irradiation. International Journal of Radiation, Oncology, Biology, Physics, 67 (4), 1052-1058. doi:10.1016/j.ijrobp.2006.10.031 |
Rutten, I., Baumert, B. G., Seidel, L., Kotolenko, S., Collignon, J., Kaschten, B., Albert, A., Martin, D., Deneufbourg, J.-M., Demanez, J.-P., & Stevenaert, A. (January 2007). Long-term follow-up reveals low toxicity of radiosurgery for vestibular schwannoma. Radiotherapy and Oncology, 82 (1), 83-89. doi:10.1016/j.radonc.2006.11.019 |
Meyns, M., Jansen, N., & Deneufbourg, J.-M. (September 2006). Place de la radiotherapie dans le traitement du cancer du sein. Indications actuelles et perspectives. Revue Médicale de Liège, 61 (9), 623-31. |
Nickers, P., Coppens, L., De Leval, J., Jansen, N., & Deneufbourg, J.-M. (June 2006). 192ir Low Dose Rate Brachytherapy for Boosting Locally Advanced Prostate Cancers after External Beam Radiotherapy: A Phase Ii Trial. Radiotherapy and Oncology, 79 (3), 329-34. doi:10.1016/j.radonc.2006.05.013 |
Nickers, P., Albert, A., Waltregny, D., & Deneufbourg, J.-M. (01 May 2006). Prognostic value of PSA nadir < or =4 ng/ml within 4 months of high-dose radiotherapy for locally advanced prostate cancer. International Journal of Radiation, Oncology, Biology, Physics, 65 (1), 73-77. doi:10.1016/j.ijrobp.2005.11.026 |
Lievens, Y., Brynaert, J. J., Deneufbourg, J.-M., Huget, P., Spaas, P., & Vanderick, J. (2006). Analysis of the Radiotherapy Expenses 2004. Bruxelles, Belgium: Ministère des Affaires sociales. |
Jansen, N., Nickers, P., & Deneufbourg, J.-M. (February 2006). L'irradiation partielle du sein et le role de la curietherapie: une nouvelle approche therapeutique pour les carcinomes mammaires de bon pronostic. Revue Médicale de Liège, 61 (2), 97-103. |
Nickers, P., Thissen, B., Jansen, N., & Deneufbourg, J.-M. (January 2006). 192-Ir or 125-I Prostate Brachytherapy as a Boost to External Beam Radiotherapy in Locally Advanced Prostatic Cancer: A Dosimetric Point of View. Radiotherapy and Oncology, 78 (1), 47-52. doi:10.1016/j.radonc.2005.09.002 |
Deneufbourg, J.-M. (2005). Telecommunication radiation oncology : a multisite linear accelerators implantation as a possible model for developing countries ? In I. Magrath & V. Shanta (Eds.), 6th INCTR Meeting Book of Abstracts CHENNAI MADRAS. Chennai, India: Cancer Institue WIA. |
De Neve, W., Storme, G., Van den Bogaert, W., Lievens, Y., Van Houtte, P., Scalliet, P., Deneufbourg, J.-M., Vander Steichel, D., & Jacquet de Haveskercke, P. (2005). Hadron therapy : between medical need and economic expediency. In Jacquet de Haveskercke Paul, Cancer treatment by light ion radiation therapy : can Belgium play a role ? (pp. 4-7). Bruxelles, Belgium: Foundation against cancer. |
Hermesse, J., Devillers, M., Deneufbourg, J.-M., & Nickers, P. (March 2005). Can intensity-modulated radiation therapy of the Paraaortic region overcome the problems of critical organ tolerance? Strahlentherapie und Onkologie, 181 (3), 185-190. doi:10.1007/s00066-005-1324-8 |
Nickers, P., Lenaerts, E., Thissen, B., & Deneufbourg, J.-M. (February 2005). Does inverse planning applied to Iridium192 high dose rate prostate brachytherapy improve the optimization of the dose afforded by the Paris system? Radiotherapy and Oncology, 74 (2), 131-136. doi:10.1016/j.radonc.2004.10.013 |
Rutten, I., Bolle, S., Kaschten, B., Stevenaert, A., Deneufbourg, J.-M., & Deprez, M. (2005). Recurrent intracranial melanocytoma associated with a nevus of Ota. Acta Neurochirurgica, 147 (3), 313-5; discussion 315. doi:10.1007/s00701-004-0457-3 |
Deneufbourg, J.-M., BARTHELEMY, N., & NICKERS, P. (2004). CHU de Liège Service de Radiothérapie - Oncologie. Liège, Belgium: Université de Liège CHU de Liège. |
Nickers, P., Thissen, B., Jansen, N., & Deneufbourg, J.-M. (October 2004). 192lr LDR brachytherapy(BT) is at least as efficient as HDR options for boosting unfavourable prostate cancers after EBRT. Proposals for future prospects. Radiotherapy and Oncology, 73 (Suppl. 1), 83. |
Deneufbourg, J.-M., & LELIEVRE, I. (01 September 2004). E-Communication for Patient Information and Support : Feasibility and Usefulness Study Among Irradiated Larynx Cancer Patients. International Journal of Radiation, Oncology, Biology, Physics, 60 (number 1 Supplt), 570 - S571. doi:10.1016/j.ijrobp.2004.07.557 |
Nickers, P., Jansen, N., Thissen, B., & Deneufbourg, J.-M. (May 2004). 192Ir LDR Brachytherapy(BT) is at least as efficient as HDR options for boosting intermediate or unfavourable prostate cancers after EBRT. Experience on 201 patients. Radiotherapy and Oncology, 71 (Suppl. 2), 124-S125. |
Barthelemy-Brichant, N., Bosquee, L., Cataldo, D., Corhay, J.-L., Gustin, M., Seidel, L., Thiry, A., Ghaye, B., Nizet, M., Albert, A., Deneufbourg, J.-M., Bartsch, P., & Nusgens, B. (01 March 2004). Increased IL-6 and TGF-beta(1) concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. International Journal of Radiation, Oncology, Biology, Physics, 58 (3), 758-767. doi:10.1016/S0360-3016(03)01614-6 |
Deneufbourg, J.-M., & Deneufbourg, J.-M. (2004). Quelle est la place de la radiothérapie dans le traitement du cancer ? [Paper presentation]. Leçon académique inaugurale du cours de Radiothérapie destiné aux élèves du Baccalauréat de spécialisation en Oncologie, Liège, Belgium. |
Piret, P., & Deneufbourg, J.-M. (March 2004). Comment je traite ... la mucite bucco-pharyngee lors d'une radiotherapie cervico-faciale. Revue Médicale de Liège, 59 (3), 120-7. |
BEAUDUIN, M. P., Deneufbourg, J.-M., DE NEVE, W., HERMANS, J., HOORNAERT, M. T., SCALLIET, P., SPAAS, P., Vanderick, J., VAN DIJCKE, J., VAN HOUTTE, P., & WELTENS, C. (2004). The management of rectal cancer in Belgium: a survey of our practice. Acta Gastro-Enterologica Belgica, 67 (1), 9-13. |
Barthelemy, N., Bosquee, L., Bartsch, P., Deneufbourg, J.-M., Albert, A., & Nusgens, B. (August 2003). Interleukin-6 and transforming growth factor-beta1 are increased in bronchoalveolar lavage fluid following thoracic radiotherapy. Lung Cancer, 41 (supp2), 173. |
Nickers, P., & Deneufbourg, J.-M. (August 2003). La curietherapie prostatique: realites et perspectives. Cancer Radiotherapie, 7 (4), 266-73. doi:10.1016/S1278-3218(03)00043-X |
BARTHELEMY, N., Bosquée, L., BARTSCH, P., Albert, A., Deneufbourg, J.-M., & Nusgens, B. (September 2002). Thoracic Radiotherapy for Lung Cancer Increases Local Concentrations of Transforming Growth Factor beta1 (TGFbeta1) [Poster presentation]. 32nd Annual Meeting of the European Society for Radiation Biology ESRB, Liège, Belgium. |
PIRET, P., & Deneufbourg, J.-M. (2002). Arguments in Favour of a Consequential Component in Late Effects among Irradiated laryngeal Cancer Patients. In J. BONIVER, L. De Saint Georges, C. Humblet, ... J. Maisin (Eds.), Proceedings of the ESRB 32nd annual meeting (pp. 59). Liège, Belgium: European Radiation Research 2002 Conference secrétariat. |
Piret, P., & Deneufbourg, J.-M. (June 2002). L'osteoradionecrose mandibulaire: epee de damocles de la radiotherapie cervico-faciale? Revue Médicale de Liège, 57 (6), 393-9. |
Deneufbourg, J.-M. (2002). Radiothérapie des Cancers Gynécologiques : effets secondaires tardifs [Paper presentation]. Associations des Médecins de la Province du Luxembourg, Neufchâteau, Belgium. |
Barthelemy, N., David, J.-L., Bosquee, L., Bury, T., Seidel, L., Albert, A., Bartsch, P., BAUGNET-MAHIEU, L., & Deneufbourg, J.-M. (March 2002). Increased TGFβ1 plasma level in patients with lung cancer: potential mechanisms. European Journal of Clinical Investigation, 32 (3), 193-198. doi:10.1046/j.1365-2362.2002.00956.x |
Vanderick, J., Baudouin, M., Deneufbourg, J.-M., Deneve, W., Hermans, J., Hoornaert, M.-T., Scalliet, P., Spaas, P., Van Dieke, V., Van Houtte, P., Vynckier, S., & Weltens, C. (December 2001). Affections bénignes et radiothérapie : une enquête de la pratique en Belgique. Cancer Radiotherapie, 5 (6), 766-9. doi:10.1016/S1278-3218(01)00136-6 |
Nickers, P., Coppens, L., Beauduin, M., Sabatier, J., Albert, A., de Leval, J., & Deneufbourg, J.-M. (2001). PSA kinetics after external beam radiotherapy alone or combined with an iridium brachytherapy boost to deliver 85 grays to prostatic adenocarcinoma. Strahlentherapie und Onkologie, 177 (2), 90-5. doi:10.1007/PL00002389 |
Stortoni, V., & Deneufbourg, J.-M. (Other coll.). (2001). Ensemble contre le cancer. Le Quinzième Jour. |
Goffart, Y., Jorissen, M., Daele, J., Vander Poorten, V., Born, J., Deneufbourg, J.-M., Zicot, A. F., & Remacle, J. M. (2000). Minimally Invasive Endoscopic Management of Malignant Sinonasal Tumours. Acta Oto-Rhino-Laryngologica Belgica, 54 (2), 221-32. |
Nickers, P., Coppens, L., Beauduin, M., Darimont, M., de Leval, J., & Deneufbourg, J.-M. (2000). Feasibility study combining low dose rate (192)Ir brachytherapy and external beam radiotherapy aiming at delivering 80-85 Gy to prostatic adenocarcinoma. Radiotherapy and Oncology, 55 (1), 41-47. doi:10.1016/S0167-8140(00)00142-0 |
Rutten, I., & Deneufbourg, J.-M. (2000). Radiotherapy in pediatric head and neck tumours. Acta Oto-Rhino-Laryngologica Belgica, 54, 1-6. |
Rutten, I., KASCHTEN, B., Rodriguez, C., Piret, P., Collignon, J., Flandroy, P., Stevenaert, A., & Deneufbourg, J.-M. (2000). Pratique de la radiothérapie stéréotaxique cérébrale selon un fractionnement classique ou en dose unique à l'aide d'un accélérateur linéaire classique. Cancer Radiotherapie, 4 (suppl 1), 99s-100. |
Barthelemy, N., Sabatier, J., Dewé, W., Albert, A., & Deneufbourg, J.-M. (November 1999). Evaluation of frequency and type of errors detected by a computerized record and verify system during radiation treatment. Radiotherapy and Oncology, 53 (2), 149-54. doi:10.1016/S0167-8140(99)00141-3 |
Piret, P., & Deneufbourg, J.-M. (1999). Radiotherapy late effects on normal tissues among patients treated for a laryngeal cancer: evaluation according to the subjective, objective, management and analytic scoring system". International Journal of Radiation, Oncology, Biology, Physics, 45. |
Paulus, P., Sambon, A., Vivegnis, D., Hustinx, R., Moreau, P., Collignon, J., Deneufbourg, J.-M., & Rigo, P. (October 1998). 18fdg-Pet for the Assessment of Primary Head and Neck Tumors: Clinical, Computed Tomography, and Histopathological Correlation in 38 Patients. Laryngoscope, 108 (10), 1578-83. doi:10.1097/00005537-199810000-00029 |
BURY, T., Nickers Philippe, CORHAY, J.-L., Deneufbourg, J.-M., & Radermecker, M. (30 August 1997). Place de la curiethérapie endobronchique à haut débit de dose dans le cancer bronchique obstructif. Médecine et Hygiène, 1997 (55), 1495-1500. |
Barthelemy, N., Bosquee, L., Baugnet, Bartsch, P., & Deneufbourg, J.-M. (1997). Pulmonary function changes in patients with lung cancer treated by combined radiation and chemotherapy. Lung Cancer. |
BARTHELEMY, N., BAUGNET, L., BOSQUEE, L., BARTSCH, P., & Deneufbourg, J.-M. (1997). Alteration of pulmonary function related to combined radiation and chemotherapy for lung neoplasm. In J.-C. Pector & J. BONIVER, Book of Abstracts 15th ABEC Meeting (pp. 3). Bruxelles, Belgium: Association belge pour l'étude du Cancer ABEC. |
Deneufbourg, J.-M., Piret, P., Boniver, F., & Colette, M. (25 January 1997). Possible role of granulocyte colony-stimulating factor (Filgastrim) in the management of radiation induced oral mucositis and dysphagia [Poster presentation]. Belgian Association for Cancer Research Meeting, Liège, Belgium. |
Deneufbourg, J.-M. (12 December 1996). Médecine palliative et fin de vie : place de la radiothérapie [Paper presentation]. Médecine palliative et fin de vie. |
Deneufbourg, J.-M., Piret, P., Bonniver, F., & Closon, M.-T. (1996). Effect of Preventive Administration of Granulocyte Colony-stimulating Factor (Filgrastim)on Dose Intensity in Neoadjuvant Chemotherapy for Head and Neck Cancers. In J. P. Shah & J. T. Johnson (Eds.), 4th ICHNC Book of Abstracts (pp. 65). Toronto, Canada: 4th ICHNC secretary. |
Deneufbourg, J.-M., Piret, P., Bonniver, F., & Collette, M. (1996). Possible Role of Granulocyte Colony-stimulating Factor (Filgrastim) in the Management of Radiation Induced Oral Mucositis and Dysphagia. In J. P. Shah & J. T. Johnson (Eds.), 4th ICHNC Book of Abstracts TORONTO (pp. 78). Toronto, Canada: 4th ICHNC secretary. |
Closon, J., & Deneufbourg, J.-M. (1995). La radiothérapie à l'Université de Liège. In R. Van Tiggelen & J. Pringot, Hundred years of Radiology in Belgium (pp. 1-pp8). Brussels, Belgium: Asklepios. |
Rigo, P., Paulus, P., JERUSALEM, G., BURY, T., Deneufbourg, J.-M., Depas, G., Benoît, T., Larock, M.-P., & Foidart, J. (1995). Indications cliniques de la tomographie à positons au 18FDG en oncologie. Expérience préliminaire et revue de la littérature. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 19, 73-89. |
Leonard, P., Delvenne, P., Collignon, J., Ghaye, B., Merchie, G., Deneufbourg, J.-M., & Boniver, J. (01 August 1994). Confrontation anatomo-clinique. Cancer thyroïdien après irradiation: revue de la littérature à propos d'un cas [letter to the editor]. Revue Médicale de Liège, 49 (8), 452-9. |
DELVENNE, P., KASCHTEN, B., Deneufbourg, J.-M., Demanez, J.-P., Stevenaert, A., Reznik, M., & BONIVER, J. (1993). Detection of Epstein-Barr virus in a case of undifferentiated nasopharyngeal carcinoma by in situ hybridization with digoxigenin-labelled PCR-generated probes. Virchows Archiv. A: Pathological Anatomy and Histopathology, 423, 145-150. doi:10.1007/BF01606589 |
Deneufbourg, J.-M. (26 July 1992). Prediction of response of Head and Neck Cancers to Neoadjuvant Chemotherapy [Poster presentation]. 3rd International Conference on Head and Neck Cancer, San Francisco, United States - California. |
Deneufbourg, J.-M. (26 July 1992). Influence of early result of radiotherapy on locoregional control and survival [Poster presentation]. 3rd International Conference on Head and Neck Cancer, San Francisco, United States - California. |
Deneufbourg, J.-M., Bouillenne, C., MAGGIPINTO, G., & Lupo, A. (26 July 1992). Lymphocytes subsets before and after neoadjuvant polychemotherapy for head and neck cancers [Poster presentation]. 3rd International Conference on Head and Neck Cancer, San Francisco, United States - California. |
Deneufbourg, J.-M. (1992). Positive correlation between neoadjuvant chemotherapy and irradiation effect in head and neck cancers : retrospective arguments and prospective validation. In L. Santi (Ed.), Interaction of Chemotherapy and Radiotherapy in solid Tumors (pp. 16). Gênes, Italy: Fondazione Regionale Cristoforo Colombo. |
Deneufbourg, J.-M., Bouillenne, C., MAGGIPINTO, G., & Lupo Aurélia. (November 1991). Changes of lymphocytes subsets after neoadjuvant chemotherapy for head and neck cancers. European Journal of Cancer and Clinical Oncology, 27 (suppl.3), 16. doi:10.1016/0277-5379(91)91160-k |
Deneufbourg, J.-M. (October 1991). Neoadjuvant chemotherapy of head and neck cancers : prediction of response by logistic discriminant analysis. European Journal of Cancer and Clinical Oncology, 27 (supplt 2), 141. |
Deneufbourg, J.-M. (October 1991). Correlation of early radiotherapy result with sustained locoregional control and long term survival. European Journal of Cancer and Clinical Oncology, 27 (supplt 2), 143. |
Deneufbourg, J.-M. (19 December 1990). Chimiothérapie néoadjuvante des cancers avancés de la tête et du cou. Médecine et Hygiène, 48 (1867), 3694-3698. |
Deneufbourg, J.-M. (November 1990). Selection of radiocurable head and neck cancers according to the degree of response to neoadjuvant chemotherapy. Annals of Oncology, 1 (supplt), 53. |
Jacquemin, D., Deneufbourg, J.-M., Al-Mahameed, G., & Castermans André. (1990). Cancer lingual : supériorité du traitement pluridisciplinaire. In Congress Proceedings 10th Congress EACMFS (pp. 224). Bruxelles, Belgium: European Association CMF Surgery. |
Deneufbourg, J.-M. (1989). Neoadjuvant chemotherapy in head and neck cancers : prediction of radiation response and basis for treatment choice. In M. A. S. J. Peckham, Abstracts Book ECCO 5. Londres, United Kingdom: ECCO 5 Conference Associates. |
Deneufbourg, J.-M. (1989). Neoadjuvant chemotherapy in head and neck cancers : prediction of radiation response and basis for selective avoidance of mutilating surgery. In A. J. Coltman & B. Leventhal (Eds.), Proceedings of 25th ASCO meeting SAN FRANCISCO (pp. 171 / 664). San Francisco, United States - California: Saunders Company. |
Deneufbourg, J.-M. (1988). Low dose neoadjuvant chemotherapy in head and neck cancers : anti-tumour activity , prediction of radiotherapy response and influence on survival. In G. C. Snow, ESO course Books I , II, III. Milan, Italy: European School of Oncology. |
Deneufbourg, J.-M. (1988). Low dose neoadjuvant chemotherapy in head and neck cancers : anti-tumour activity, prediction of radiotherapy response and influence on survival. In M. Weil, D. Khayat, ... C. Jacquillat (Eds.), Neoadjuvant Chemotherapy (pp. 327-332). Paris, France: INSERM. |
Deneufbourg, J.-M. (1987). Oncologie en Algérie : situation 88. Liège, Belgium: Université de Liège Faculté de Médecine. https://orbi.uliege.be/handle/2268/289005 |
Deneufbourg, J.-M., Lupo, A., Bouillenne, C., Reuter, A., Ghysen, P., Lopez, M., & Franchimont, P. (November 1987). Immunological modifications associated with radiotherapy of larynx cancer : longitudinal analysis and correlations with the course of disease [Poster presentation]. 4th European Conference on Clinical Oncology and Cancer Nursing, Madrid, Spain. |
Lupo, A., & Deneufbourg, J.-M. (November 1987). Radiation induced xerostomia : evaluation of consequences and effects of a mucin containing artificial saliva [Poster presentation]. 4th European Conference on Clinical Oncology and Cancer Nursing, Madrid, Spain. |
Lupo, A., & Deneufbourg, J.-M. (November 1987). Evaluation form to test the required knowledge for a safe handling of cytotoxic agents [Poster presentation]. 4th European Conference on Clinical Oncology and Cancer Nursing, Madrid, Spain. |
Deneufbourg, J.-M. (1987). Neoadjuvant chemotherapy and hypofractionated irradiation in the treatment of head and neck cancers. In IAEA Autriche Vienne, Radiotherapy in Developing Countries (pp. 111-120). Vienne, Austria: IAEA. |
Deneufbourg, J.-M., Closon, M.-T., Lemmens, M., Lupo, A., Résimont, N., Balsat, A., & Lemaire, A. (1987). Recommandations pour une manipulation sans risque des cytostatiques. Liège, Belgium: Université de Liège Service de radiothérapie. |
Deneufbourg, J.-M., & Lupo, A. (01 September 1986). Evaluation des troubles salivaires et gustatifs après radiothérapie de cancers de la tête et du cou. Revue Médicale de Liège, XLI (17), 649-653. |
Deneufbourg, J.-M. (1986). Neoadjuvant chemotherapy in head and neck cancers with low dose combination of bleomycin, etoposide and cis-platinum. In C. Jacquillat, M. Weil, ... D. Khayat (Eds.), Neoadjuvant Chemotherapy (pp. 377-382). Paris, France: INSERM. |
Deneufbourg, J.-M. (1986). Cancer et immunité. In M. Wayoff & C. Freche, Immunologie Allergie en O R L (pp. 327-335). Paris, France: Arnette. |
Deneufbourg, J.-M. (1985). Split-course irradiation of larynx carcinoma : long term results and tolerance. In J. Einhorn (Ed.), Book of Abstracts (pp. 19). Stockholm, Sweden: ECCO 3 secretary. |
Deneufbourg, J.-M. (1985). Initial chemotherapy in head and neck cancers : efficiency and harmlessness of bleomycin + vepesid + platinol (BVP). In J. Einhorn (Ed.), Book of Abstracts (pp. 21). Stockholm, Sweden: ECCO 3 secretary. |
Lupo, A., & Deneufbourg, J.-M. (1985). Influence of information mode on patient's education level. In J. Einhorn (Ed.), Book of Abstracts (pp. 237). Stockholm, Sweden: ECCO 3 secretary. |
Lupo, A., & Deneufbourg, J.-M. (1985). Changes in taste and salivary function after radiotherapy : specific roles of the nurse in evaluation and treatment. In J. Einhorn (Ed.), Book of Abstracts (pp. 34). Stockholm, Sweden: ECCO 3 secretary. |
Deneufbourg, J.-M. (1984). Influence of treatment mode on host immunity after cure from transplantable tumours : the advantage radiotherapy over surgery and chemotherapy. In K. E. S. A. Hellmann (Ed.), Treatment of metastasis : problems and prospects (1984, pp. 3.9). Londres, United Kingdom: Taylor & Francis. |
Deneufbourg, J.-M. (1984). Split-Course Irradiation in the Treatment of Larynx Carcinoma. In P. B. Chretien, Program of Continuing Education University of Maryland School of Medicine : International Conference on Head and Neck Cancer, Baltimore July 22-27 1984 (pp. 84). United States: Lancaster press Inc. |
Deneufbourg, J.-M., & Bouillenne, C. (1984). Positive correlation between HLA B27 and Larynx Cancer. In P. B. Chretien, Program of continuing Education of Maryland School of Medicine International Conference on head and Neck Cancer Baltimore July 22-27 1984. United States: Lancaster Press Inc. |
Deneufbourg, J.-M. (28 May 1984). Radiothérapie concentrée discontinue de cancers laryngés [Poster presentation]. IV ème Forum de Cancérologie, Paris, France. |
Deneufbourg, J.-M. (November 1983). BVP chemotherapy(Bleomycin, Vepesid, Platinol )before radical treatment in head and neck cancers [Poster presentation]. 2nd European Conference on Clinical Oncology and Cancer Nursing, Amsterdam, Netherlands. |
Lupo, A., & Deneufbourg, J.-M. (November 1983). A patient education guide in a Radiotherapy department : an effort towards self-care [Poster presentation]. 2nd European Conference on Clinical Oncology and Cancer Nursing, Amsterdam, Netherlands. |
Deneufbourg, J.-M. (1983). Influence of treatment mode on host immunity after cure from transplantable tumours : advantage radiotherapy over surgery and chemotherapy. In J. Broerse, G. Barendsen, H. Kal, ... A. van der Kogel, Tumours Biology and Therapy Proceedings of the 7th ICRR (pp. 2-05-1à3). Amsterdam, Netherlands: Martinus Nijhof. |
Deneufbourg, J.-M. (07 June 1983). Bléomycine, VP 16 et cis -Platinum avant traitement radical de cancers de la tête et du cou : premiers résultats d'une étude pilote [Poster presentation]. 3ème Forum de Cancérologie PARIS, Paris, France. |
Deneufbourg, J.-M., & Bouillenne, C. (1982). Positive correlation between HLA-B35 and breast cancer incidence. In 13th UICC Cancer Congress Proceedings (pp. 523). Genève, Switzerland: Union Internationale contre le cancer UICC. |
Deneufbourg, J.-M., & Salmon, J. (1982). Immune complexes and breast cancer : influence of radiotherapy and prognostic implications. In Proceedings of 13th Cancer Congress (pp. 196). Genève, Switzerland: Union Internationale contre le cancer UICC. |
Deneufbourg, J.-M. (1982). BVP chemotherapy (Bleomycin, VP 16, Cis-platinum) before radical treatment in head and neck cancers : a pilot study. In K. Karrer, Conference Book 11th International Congress of Chemotherapy (pp. 12.1.11). Vienne, Austria: Wiener Medizinische Akademie. |
Deneufbourg, J.-M., & Bouillenne, C. (07 June 1982). Corrélation positive entre HLA-B35 et l'incidence du cancer du sein [Poster presentation]. 2 ème Forum de Cancérologie PARIS, Paris, France. |
Deneufbourg, J.-M. (June 1982). Enhancement of concomitant immunity after radiation therapy and immunotherapy in a syngeneic murine tumour system. Acta Radiologica. Oncology, 21 (5), 345-348. doi:10.3109/02841868209134025 |
Deneufbourg, J.-M., & Salmon, J. (1981). Immune complexes and breast cancer : influence of radiotherapy and prognostic implications. In Union internationale contre le cancer (Ed.), Book of Conference Abstracts. Berne, Switzerland: Schweizerische Krebsliga. |
Deneufbourg, J.-M. (1981). Radiothérapie concentrée discontinue dans les cancers de la lèvre : résultats thérapeutiques et esthétiques. In J. J. Mazeron & P. Richard (Eds.), Livre des Résumés (pp. 1-7). Padoue, Italy: Divisione di Radioterapia Ospedale civile. |
Deneufbourg, J.-M., & Bouillenne, C. (1980). Corrélation entre les groupes HLA et le cancer du larynx. Incidence et pronostic à 5 ans. Bulletin du Cancer, 67 (5), 531-534. |
Deneufbourg, J.-M. (September 1979). Anti-tumour effect of an aromatic retinoic acid analog in a mouse syngeneic transplantable sarcoma. Biomedicine Express, 31, 122-123. |
Bouillenne, C., & Deneufbourg, J.-M. (1979). Positive Correlation between Breast Cancer Incidence and HLA Antigens. Oncology, 36, 156-159. |
Deneufbourg, J.-M. (1979). Radiothérapie concentrée discontinue des cancers de la peau et de la lèvre inférieure. JBR-BTR, 62, 535-543. |
Deneufbourg, J.-M. (02 March 1977). Radiothérapie hypofractionnée de cancers de la tête et du cou adaptée au contexte sanitaire d'un pays en voie de développement : premiers résultats à court terme au Centre Pierre et Marie Curie d'Alger 1972-1974 [Paper presentation]. Conférence d'enseignement post-universitaire : Service universitaire de Radiothérapie, Liège, Belgium. |
Bouillenne, C., & Deneufbourg, J.-M. (1976). HLA and Breast Cancer. In J. S. A. Dausset (Ed.), H L A and Disease (pp. 219). Paris, France: Editions INSERM. |
Deneufbourg, J.-M., & Bouillenne, C. (1976). HLA and larynx cancer. In J. S. A. Dausset (Ed.), HLA and Disease (pp. 222). Paris, France: Editions INSERM. |
Dony, G., Duchateau, J.-P., & Deneufbourg, J.-M. (1976). Les tumeurs malignes du cavum. Acta Oto-Rhino-Laryngologica Belgica, 30 (3), 269-288. |
Deneufbourg, J.-M. (May 1975). Radiocurability of a transplantable murine sarcoma as influenced by immune competence of the host and adjuvant active specific immunotherapy. Strahlentherapie, 149 (4), 457-462. |
Deneufbourg, J.-M. (January 1972). Radiothérapie tumorale et status immunitaire de l'hôte dans un système allogénique. Bulletin du Cancer, 59 (1), 61-76. |
Deneufbourg, J.-M., & Wéry Paul. (May 1967). Chimiothérapie et Cancer en Gynécologie [Paper presentation]. Conférence d'enseignement post-universitaire : Service universitaire de Gynécologie, Liège, Belgium. |